Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Value share of generic pharmaceuticals in Czechia 2001-2017

Share of generic pharmaceuticals market value in Czechia from 2001 to 2017

by Conor Stewart, last edited Nov 8, 2019
Value share of generic pharmaceuticals in Czechia 2001-2017 This statistic displays the value share of the generic pharmaceutical market in Czechia from 2001 to 2017. In 2017, the generic pharmaceutical market value amounted to 28.2 percent, the highest figure in the provided time interval.
Show more

Share of generic pharmaceuticals market value in Czechia from 2001 to 2017

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Generics and biosimilars in Italy"
  • Global overview
The most important statistics
  • Italy: pharmaceutical market and industry
  • Biosimilar drugs
  • Generic drugs
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.